
Delia M. Ramirez
Examiner (ID: 4462)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 1518 |
| Issued Applications | 818 |
| Pending Applications | 200 |
| Abandoned Applications | 534 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17052553
[patent_doc_number] => 20210261987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => PRODUCTION OF ETHANOL WITH ONE OR MORE CO-PRODUCTS IN YEAST
[patent_app_type] => utility
[patent_app_number] => 17/182061
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182061
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182061 | PRODUCTION OF ETHANOL WITH ONE OR MORE CO-PRODUCTS IN YEAST | Feb 21, 2021 | Abandoned |
Array
(
[id] => 17067617
[patent_doc_number] => 20210269832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => METHODS AND COMPOSITIONS FOR ENHANCED ETHANOL PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/173412
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173412
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/173412 | METHODS AND COMPOSITIONS FOR ENHANCED ETHANOL PRODUCTION | Feb 10, 2021 | Abandoned |
Array
(
[id] => 18406071
[patent_doc_number] => 20230167422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => Parent Phytase Variant
[patent_app_type] => utility
[patent_app_number] => 17/997037
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997037
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997037 | Parent Phytase Variant | Feb 2, 2021 | Pending |
Array
(
[id] => 18406071
[patent_doc_number] => 20230167422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => Parent Phytase Variant
[patent_app_type] => utility
[patent_app_number] => 17/997037
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997037
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997037 | Parent Phytase Variant | Feb 2, 2021 | Pending |
Array
(
[id] => 18478087
[patent_doc_number] => 11691817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Yeast cells having disrupted pathway from dihydroxyacetone phosphate to glycerol
[patent_app_type] => utility
[patent_app_number] => 17/154190
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16225
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154190
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/154190 | Yeast cells having disrupted pathway from dihydroxyacetone phosphate to glycerol | Jan 20, 2021 | Issued |
Array
(
[id] => 17126501
[patent_doc_number] => 20210301269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => RECOMBINANT CRISPR-CAS9 NUCLEASES WITH ALTERED PAM SPECIFICITY
[patent_app_type] => utility
[patent_app_number] => 17/154826
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154826
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/154826 | RECOMBINANT CRISPR-CAS9 NUCLEASES WITH ALTERED PAM SPECIFICITY | Jan 20, 2021 | Abandoned |
Array
(
[id] => 17126501
[patent_doc_number] => 20210301269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => RECOMBINANT CRISPR-CAS9 NUCLEASES WITH ALTERED PAM SPECIFICITY
[patent_app_type] => utility
[patent_app_number] => 17/154826
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154826
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/154826 | RECOMBINANT CRISPR-CAS9 NUCLEASES WITH ALTERED PAM SPECIFICITY | Jan 20, 2021 | Abandoned |
Array
(
[id] => 17953662
[patent_doc_number] => 11479756
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Ketoreductase polypeptides for the reduction of acetophenones
[patent_app_type] => utility
[patent_app_number] => 17/149463
[patent_app_country] => US
[patent_app_date] => 2021-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 44198
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17149463
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/149463 | Ketoreductase polypeptides for the reduction of acetophenones | Jan 13, 2021 | Issued |
Array
(
[id] => 18223102
[patent_doc_number] => 20230062096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 17/792101
[patent_app_country] => US
[patent_app_date] => 2021-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792101
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792101 | COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY | Jan 10, 2021 | Pending |
Array
(
[id] => 18223102
[patent_doc_number] => 20230062096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 17/792101
[patent_app_country] => US
[patent_app_date] => 2021-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792101
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792101 | COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY | Jan 10, 2021 | Pending |
Array
(
[id] => 17258853
[patent_doc_number] => 20210371838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => NON-STANDARD AMINO ACID CONTAINING COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/144946
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144946
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/144946 | Non-standard amino acid containing compositions and uses thereof | Jan 7, 2021 | Issued |
Array
(
[id] => 16848081
[patent_doc_number] => 20210148826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => Quantitative Flagellar Fluorescent Markers and Standards
[patent_app_type] => utility
[patent_app_number] => 17/142090
[patent_app_country] => US
[patent_app_date] => 2021-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17142090
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/142090 | Quantitative Flagellar Fluorescent Markers and Standards | Jan 4, 2021 | Abandoned |
Array
(
[id] => 17497782
[patent_doc_number] => 11286475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Tyrosol-producing recombinant
[patent_app_type] => utility
[patent_app_number] => 17/134633
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3754
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17134633
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/134633 | Tyrosol-producing recombinant | Dec 27, 2020 | Issued |
Array
(
[id] => 18739899
[patent_doc_number] => 20230348866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/786913
[patent_app_country] => US
[patent_app_date] => 2020-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786913
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786913 | BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS | Dec 23, 2020 | Pending |
Array
(
[id] => 17968470
[patent_doc_number] => 11485987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => Methods for inducing bioorthogonal reactivity
[patent_app_type] => utility
[patent_app_number] => 17/132532
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 25118
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17132532
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/132532 | Methods for inducing bioorthogonal reactivity | Dec 22, 2020 | Issued |
Array
(
[id] => 17274815
[patent_doc_number] => 20210381013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => ENZYMATIC CYCLIZATION OF HOMOFARNESYLIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/131930
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16407
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131930
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/131930 | ENZYMATIC CYCLIZATION OF HOMOFARNESYLIC ACID | Dec 22, 2020 | Pending |
Array
(
[id] => 16932762
[patent_doc_number] => 20210198651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => METHOD OF PURIFYING HIGH-PURITY UBIQUITIN
[patent_app_type] => utility
[patent_app_number] => 17/128550
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17128550
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/128550 | Method of purifying native ubiquitin | Dec 20, 2020 | Issued |
Array
(
[id] => 18229719
[patent_doc_number] => 20230068713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => HOST CELLS AND THEIR USE FOR PRODUCING RIBITOL AND FURTHER MONOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/779561
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779561
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779561 | HOST CELLS AND THEIR USE FOR PRODUCING RIBITOL AND FURTHER MONOSACCHARIDES | Dec 16, 2020 | Pending |
Array
(
[id] => 17604294
[patent_doc_number] => 11332767
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Nucleic acids and recombinant host cells expressing acetylserotonin O-methyltransferase (ASMT) variants and their use in producing melatonin
[patent_app_type] => utility
[patent_app_number] => 17/109715
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 12049
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/109715 | Nucleic acids and recombinant host cells expressing acetylserotonin O-methyltransferase (ASMT) variants and their use in producing melatonin | Dec 1, 2020 | Issued |
Array
(
[id] => 17860018
[patent_doc_number] => 11441165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-13
[patent_title] => Biosynthetic production of steviol glycosides rebaudioside J and rebaudioside N
[patent_app_type] => utility
[patent_app_number] => 17/109473
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 16091
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109473
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/109473 | Biosynthetic production of steviol glycosides rebaudioside J and rebaudioside N | Dec 1, 2020 | Issued |